Enzon Files S-4 for Merger with Viskase, Proposing 1-for-100 Reverse Stock Split and Significant Dilution for Existing Common Shareholders

summarizeSummary

Enzon filed an S-4 for its merger with Viskase, detailing a 1-for-100 reverse stock split and significant dilution for existing common shareholders, who will own ~5.1% of the combined entity, while Icahn-affiliated parties will hold ~93.32%.

check_boxKey Events · M&A and Partnerships · ENZN

• Merger with Viskase Companies, Inc.

  Enzon will merge with Viskase, with Viskase surviving as a wholly-owned subsidiary and the combined entity operating as "Viskase Holdings, Inc.".

• Extreme Dilution for Existing Common Stockholders

  Current Enzon common stockholders are projected to own approximately 5.1% of the combined company post-merger.

• 1-for-100 Reverse Stock Split Proposed

  A reverse stock split is planned immediately prior to the merger, reducing the number of outstanding shares.

• Series C Preferred Stock Exchange Offer

  Enzon is offering to exchange all Series C Preferred Stock for common stock, a condition for the merger. Icahn Enterprises Holdings L.P. (IEH Parties) have already agreed to exchange their 98.2% stake.

auto_awesomeAnalysis · ENZN · Life Sciences

Enzon Pharmaceuticals, an acquisition vehicle, has filed a comprehensive S-4 registration statement detailing its proposed merger with Viskase Companies, Inc. The transaction is highly transformative, with existing Enzon common stockholders expected to own only approximately 5.1% of the combined entity, which will be renamed "Viskase Holdings, Inc." This significant dilution is coupled with a proposed 1-for-100 reverse stock split of Enzon's common stock. The merger is also contingent on an exchange offer for Enzon's Series C Preferred Stock, largely held by Icahn Enterprises Holdings L.P. (IEH Parties), who will ultimately control approximately 93.32% of the combined company. Viskase has faced material financial deterioration and a "going concern" qualification, making this merger a critical event for its survival, while for Enzon, it represents a complete change in business and capital structure. The overwhelming control by IEH Parties post-merger means minority shareholders will have very limited influence.